As the opioid crisis continues to grip the nation, it leaves another problem in its wake: drug testing fraud. For bad actors, opioid drug testing is an opportunity to exploit a crisis for extra reimbursement. While few of these schemes are new, detection can be slowed by siloed data. The good news is that information sharing and collaboration helps to catch these schemes faster, as we explore in our on-demand webinar, Catching potential drug testing fraud: A case study of successful investigative techniques.
In this on-demand webinar, we're joined by Shawn Mullen, director of SIU at MetroPlus Health Plan, to discuss a collaborative case study of a New York laboratory provider identified through data analysis and its association with a previously indicted pain management provider. Through a joint effort, Cotiviti and MetroPlus Health Plan used information sharing, link analysis, peer comparison, and a medical review of records to identify an overpayment of more than $1 million.
I hope you’ll view our on-demand webinar as we walk through how to:
Don’t miss this opportunity to discover new ways to catch fraud earlier, improving efficiency and savings.